Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.
We don't have enough public data on OMID to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.
Market Performance
Stock returned +10.0% over the past year, broadly in line with market conditions.
Analyst Target
Analyst consensus price target: $0.17.
What is Omid Holdings Inc?
, a health and wellness company, engages in the manufacture and sale of CBD-based products.
OMID · Verdict
Moderate reward · moderate risk
OMID leads on volatility with the rest of the factors in line with peers.
Based on 38% data coverage
OMID · Verdict
What’s working & what to watch
Strengths 1
Volatility95/100
Top decile vs peers
No major weaknesses flagged.
Model-based scoring. For information only — not financial advice.
What is Omid Holdings Inc?
, a health and wellness company, engages in the manufacture and sale of CBD-based products. The company is based in Phillipsburg, New Jersey. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 2.65M.
Financial Highlights
Investment Breakdown
📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.
Analysis
Reward: Moderate (52)
The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.